The global pet healthcare market is projected to grow from $239.29 billion in 2023 to $255.96 billion in 2024, with a CAGR of 7.0%. Key drivers include an increasing pet population, advancements in veterinary care, and a focus on preventive health. By 2028, the market is expected to reach $353.66 billion, driven by trends such as pet humanization and economic prosperity.
The global small-molecule injectable drugs market reached $188.9 billion in 2021, with a projected growth rate of 8% CAGR, expected to hit $837.8 billion by 2030. North America leads the market with a 37% share, driven by increased R&D and product approvals, while Europe is anticipated to grow the fastest due to rising demand for minimally invasive procedures. Intravenous injections accounted for 30% of the market, highlighting their critical role in rapid drug administration.
Medical journalism has emerged as the leading segment in the medical writing market, driven by the public's demand for reliable health information and the rise of online platforms. North America holds a significant market share due to its robust pharmaceutical industry and regulatory frameworks, while the global market is projected to grow from $3.15 billion in 2022 to $7.95 billion by 2032, at a CAGR of 9.7%. The clinical writing segment is crucial, accounting for 36.8% of the market, reflecting the increasing number of clinical trials and stringent regulatory requirements.
The bile duct cancer market is expanding, driven by a shortage of specialists and healthcare system challenges in developing countries. In 2021, North America led the market with a 37.1% share and $185.4 billion in revenue, fueled by increased R&D and rising cancer prevalence. The Asia-Pacific region is projected to grow the fastest through 2030, supported by awareness programs and private investments.
The global choline chloride market, valued at $500 million in 2021, is projected to reach $711.65 million by 2030, growing at a CAGR of 4%. Key drivers include rising demand in the food industry, pharmaceuticals, and personal care, alongside increased use in animal feed to enhance livestock health. The 50% choline chloride segment led the market in 2021, accounting for 21.1% of market share.
The global pharmaceutical coating equipment market, valued at $0.79 billion in 2021, is projected to reach $1.4 billion by 2030, growing at a CAGR of 7.3%. North America leads with a 39.3% market share, driven by new product development and the rise of generic drugs, while Europe is expected to grow the fastest due to increased demand for effective drugs. Key players include Ohara Technologies, ACG, and Glatt GmbH, with significant developments enhancing their market positions.
SNIPR BIOME ApS has initiated the first human clinical trial for SNIPR001, targeting E. coli colonization in healthy volunteers, set to begin in the first half of 2022. The global CRISPR technology market is projected to grow significantly, with North America leading in market share, driven by advancements in biomedical applications and increasing research activities.
Qualcomm, Inc. focuses on designing, developing, and marketing CDMA systems and software, with 83.8% of net sales from communication systems and 16.2% from licensing. Geographically, 63.6% of sales come from China and Hong Kong, followed by Vietnam (13.7%) and South Korea (7.2%).
Qualcomm, Inc. focuses on designing, developing, and marketing CDMA systems and software, with 83.8% of net sales from communication systems and 16.2% from licensing. Geographically, 63.6% of sales come from China and Hong Kong, followed by Vietnam (13.7%) and South Korea (7.2%).
The companion animal healthcare market is experiencing significant growth, driven by an increase in pet ownership and demand for improved care standards. Key factors include the rise of nuclear families and government initiatives promoting veterinary products, although counterfeit drugs pose a challenge. The market is segmented by product type and animal type, with major players including Elanco, Zoetis, and Merck.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.